Please use this identifier to cite or link to this item:
http://hdl.handle.net/10362/167065
Title: | Recommendations for asthma monitoring in children |
Author: | Papadopoulos, Nikolaos G. Custovic, Adnan Deschildre, Antoine Gern, James E. Nieto Garcia, Antonio Miligkos, Michael Phipatanakul, Wanda Wong, Gary Xepapadaki, Paraskevi Agache, Ioana Arasi, Stefania Awad El-Sayed, Zeinab Bacharier, Leonard B. Bonini, Matteo Braido, Fulvio Caimmi, Davide Castro-Rodriguez, Jose A. Chen, Zhimin Clausen, Michael Craig, Timothy Diamant, Zuzana Ducharme, Francine M. Ebisawa, Motohiro Eigenmann, Philippe Feleszko, Wojciech Fierro, Vincezo Fiocchi, Alessandro Garcia-Marcos, Luis Goh, Anne Gómez, René Maximiliano Gotua, Maia Hamelmann, Eckard Hedlin, Gunilla Hossny, Elham M. Ispayeva, Zhanat Jackson, Daniel J. Jartti, Tuomas Jeseňák, Miloš Kalayci, Omer Kaplan, Alan Konradsen, Jon R. Kuna, Piotr Lau, Susanne Le Souef, Peter Lemanske, Robert F. Levin, Michael Makela, Mika J. Mathioudakis, Alexander G. Mazulov, Oleksandr Morais-Almeida, Mário Murray, Clare Nagaraju, Karthik Novak, Zoltan Pawankar, Ruby Pijnenburg, Marielle W. Pite, Helena Pitrez, Paulo M. Pohunek, Petr Price, David Priftanji, Alfred Ramiconi, Valeria Rivero Yeverino, Daniela Roberts, Graham Sheikh, Aziz Shen, Kun Ling Szepfalusi, Zsolt Tsiligianni, Ioanna Turkalj, Mirjana Turner, Steve Umanets, Tetiana Valiulis, Arunas Vijveberg, Susanne Wang, Jiu Yao Winders, Tonya Yon, Dong Keon Yusuf, Osman M. Zar, Heather J. |
Keywords: | asthma management biomarkers childhood consensus diagnosis guidelines therapy Pediatrics, Perinatology, and Child Health Immunology and Allergy Immunology |
Issue Date: | Apr-2024 |
Abstract: | Monitoring is a major component of asthma management in children. Regular monitoring allows for diagnosis confirmation, treatment optimization, and natural history review. Numerous factors that may affect disease activity and patient well-being need to be monitored: response and adherence to treatment, disease control, disease progression, comorbidities, quality of life, medication side-effects, allergen and irritant exposures, diet and more. However, the prioritization of such factors and the selection of relevant assessment tools is an unmet need. Furthermore, rapidly developing technologies promise new opportunities for closer, or even “real-time,” monitoring between visits. Following an approach that included needs assessment, evidence appraisal, and Delphi consensus, the PeARL Think Tank, in collaboration with major international professional and patient organizations, has developed a set of 24 recommendations on pediatric asthma monitoring, to support healthcare professionals in decision-making and care pathway design. (Figure presented.). |
Peer review: | yes |
URI: | http://hdl.handle.net/10362/167065 |
DOI: | https://doi.org/10.1111/pai.14129 |
ISSN: | 0905-6157 |
Appears in Collections: | NMS - Artigos em revista internacional com arbitragem científica |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Pediatric_Allergy_Immunology_-_2024_-_Papadopoulos_-_Recommendations_for_asthma_monitoring_in_children_A_PeARL_document.pdf | 1,15 MB | Adobe PDF | View/Open |
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.